about
Neutrophils in Cancer: Two Sides of the Same CoinA delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disordersThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerMoving targets: Emerging roles for MMPs in cancer progression and metastasisMatrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTUREBiochemical and spectroscopic characterization of the catalytic domain of MMP16 (cdMMP16)An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitorsThe case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discoveryWhy don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionRalB regulates contractility-driven cancer dissemination upon TGFβ stimulation via the RhoGEF GEF-H1Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxideTumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Enzymatic activation of a matrix metalloproteinase inhibitorMatrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzymeEffect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis.Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approachTumor associated macrophages and neutrophils in tumor progression.PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1)MMP9 is protective against lethal inflammatory mass lesions in the mouse colon.Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis.Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophyPleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microgliaPathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model.Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstructionPRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancerMatrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signalingMatrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells
P2860
Q26773072-2832CA13-B4B5-444A-9E71-AE1841854B70Q26797397-815E789A-CE33-4B52-98C2-5CD964887188Q27004958-E78F4E7B-5C04-4AA4-B1CE-C5E661A0B47DQ27008735-E0506F26-8F03-4880-A1CF-2C6709BF969FQ27678085-71B2CFEF-511C-4A1D-8142-C764CD0FD896Q28116011-203FA551-61CD-45BD-BDC2-35EBA1B2983DQ28485109-CAE5171F-9A50-425E-964E-3C781C5A1088Q28751328-7052AD8D-055C-4FEF-881E-234E1D9D3E48Q29614274-D524B826-8E60-43D2-B48E-8CA8A3E0B0DCQ30657060-07D027F5-6C79-4868-B63D-CE1949FCFF0DQ33729335-FC4D097D-F3F8-421F-A574-700647430870Q33737922-953046A3-7B70-4539-903C-96DE846EDC01Q33757096-4E7FCB59-1981-4B5A-AAF2-0CFB570130C7Q33839227-BA547506-32BF-46B0-8100-C9F5AE652947Q33915005-218E1651-649F-4817-AA63-4CB237D6F8F5Q33947243-B9F06A86-6F06-4A99-82E2-E2D316B5A76FQ33977030-58DBB81E-4C8D-430A-9A8F-5834FA02ECAAQ34077691-ACC1747C-B3E8-40B7-AC7A-08CEFD216179Q34088459-78F05A82-307B-423B-B54C-61CF40DEF1CCQ34192005-B6418AFF-4265-454D-BF38-A7E27DCF30AFQ34306107-FE1CDEAF-D9AE-4103-AA63-DE657290504CQ34490917-19B60841-8796-453A-9C36-0C8C9931F714Q34611765-4AC8990E-6E5A-4A7D-89C0-8CE64CF4FB65Q34631606-E2A041A0-8F3E-406E-88CA-ED9BCA06D04EQ35103645-CEB3A701-18B9-47F9-93ED-D6A257F678B4Q35175749-1CD49F23-1051-4D3B-88B3-9ED5F6C8FA91Q35233950-9F186183-BE41-4582-9D86-D0B99812A767Q35694281-A052A80D-1564-4AED-B629-764FB93694CEQ35696343-434CEEAE-A05D-48D3-B259-AC7F46A88F86Q35767677-DA04DD3C-291E-4297-8555-97111470F5DCQ35922535-39BCC6BE-3313-4A6A-B438-7D1363FC2D58Q36009930-990E0A22-E491-4815-A52B-F6A2DE41170FQ36190097-59CE7D29-4235-48B2-8424-B6DB5C703393Q36205784-C618EE0F-8EF8-4CCB-9A18-9958847FC86AQ36219151-33CB0D07-B7A7-4020-B109-CB9DFB916D05Q36493144-CC29BE63-26FB-4A2C-9C33-BB9E6B85A3B2Q36644577-046B9927-548F-45E0-BEA2-9D97919B1643Q36689362-644ACE2B-4341-41F3-864F-EC55427C0498Q36895696-C5AD68A1-DC69-483A-A7EF-2096A5948683Q36910024-EF9115B3-2751-4741-A787-B08D26F36B25
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
MMPs as therapeutic targets--still a viable option?
@en
type
label
MMPs as therapeutic targets--still a viable option?
@en
prefLabel
MMPs as therapeutic targets--still a viable option?
@en
P2860
P1476
MMPs as therapeutic targets--still a viable option?
@en
P2860
P356
10.1016/J.SEMCDB.2007.06.006
P577
2007-07-06T00:00:00Z